Moderna shares gained nearly 14 per cent on Tuesday as brokerage Oppenheimer upgraded the stock to “outperform” and the vaccine maker’s CEO reiterated the company’s goal of achieving sales growth in 2025.
Source: ctv business
Vaccine maker Moderna jumps on Oppenheimer upgrade, 2025 sales growth goal